Top

Published in:

16-08-2023 | Atrial Fibrillation

COMP Improves Ang-II-Induced Atrial Fibrillation via TGF-β Signaling Pathway

Authors: XiaoBi Cai, Mingliang Li, Ying Zhong, Wenkun Yang, Zhu Liang

Published in: Cardiovascular Toxicology | Issue 9-10/2023

Abstract

Cartilage oligomeric matrix protein (COMP) regulates transforming growth factor-β (TGF-β) signaling pathway, which has been proved to be associated with skin fibrosis and pulmonary fibrosis. Atrial fibrosis is a major factor of atrial fibrillation (AF). Nevertheless, the interaction between COMP and TGF-β as well as their role in AF remains undefined. The purpose of this study is to clarify the role of COMP in AF and explore its potential mechanism. The hub gene of AF was identified from two datasets using bioinformatics. Furthermore, it was verified by the downregulation of COMP in angiotensin-II (Ang-II)-induced AF in mice. Moreover, the effect on AF was examined using CCK8 assay, ELISA, and western blot. The involvement of TGF-β pathway was further discussed. The expression of COMP was the most significant among all these hub genes. Our experimental results revealed that the protein levels of TGF-β1, phosphorylated Smad2 (P-Smad2), and phosphorylated Smad3 (P-Smad3) were decreased after silencing COMP, which indicated that COMP knockdown could inhibit the activation of TGF-β pathway in AF cells. However, the phenomenon was reversed when the activator SRI was added. COMP acts as a major factor and can improve Ang-II-induced AF via TGF-β signaling pathway. Thus, our research enriches the understanding of the interaction between COMP and TGF-β in AF, and provides reference for the pathogenesis and diagnosis of AF.

Available only for authorised users

Yamamoto, C., & Trayanova, N. A. (2022). Atrial fibrillation: Insights from animal models, computational modeling, and clinical studies. eBioMedicine, 85(104310), 26.

Wang, W., Tian, B., Ning, Z., & Li, X. (2022). Research progress of LncRNAs in atrial fibrillation. Molecular Biotechnology, 64(7), 758–772.CrossRefPubMed

Suwa, Y., Miyasaka, Y., Taniguchi, N., Harada, S., Nakai, E., & Shiojima, I. (2022). Atrial fibrillation and stroke: Importance of left atrium as assessed by echocardiography. Journal of Echocardiography, 20(2), 69–76. https://doi.org/10.1007/s12574-021-00561-6CrossRefPubMed

Camm, A. J., Naccarelli, G. V., Mittal, S., Crijns, H., Hohnloser, S. H., Ma, C. S., Natale, A., Turakhia, M. P., & Kirchhof, P. (2022). The increasing role of rhythm control in patients with atrial fibrillation: JACC state-of-the-art review. Journal of the American College of Cardiology, 79(19), 1932–1948.CrossRefPubMed

Wegner, F. K., Plagwitz, L., Doldi, F., Ellermann, C., Willy, K., Wolfes, J., Sandmann, S., Varghese, J., & Eckardt, L. (2022). Machine learning in the detection and management of atrial fibrillation. Clinical Research in Cardiology, 111(9), 1010–1017.CrossRefPubMedPubMedCentral

Sehrawat, O., Kashou, A. H., & Noseworthy, P. A. (2022). Artificial intelligence and atrial fibrillation. Journal of Cardiovascular Electrophysiology, 33(8), 1932–1943.CrossRefPubMedPubMedCentral

Posey, K. L., Coustry, F., & Hecht, J. T. (2018). Cartilage oligomeric matrix protein: COMPopathies and beyond. Matrix Biology, 71–72, 161–173. https://doi.org/10.1016/j.matbio.2018.02.023CrossRefPubMedPubMedCentral

Liang, Y., Fu, Y., Qi, R., Wang, M., Yang, N., He, L., Yu, F., Zhang, J., Yun, C.-H., Wang, X., Liu, J., & Kong, W. (2015). Cartilage oligomeric matrix protein is a natural inhibitor of thrombin. Blood, 126(7), 905–914. https://doi.org/10.1182/blood-2015-01-621292CrossRefPubMed

Nakayama, H., Endo, Y., Aota, S., Sato, M., Fujita, T., & Kikuchi, S. (2003). Novel mutations of the cartilage oligomeric matrix protein (COMP) gene in two Japanese patients with pseudoachondroplasia. Oncology Reports, 10(4), 871–873.PubMed

10.

Englund, E., Bartoschek, M., Reitsma, B., Jacobsson, L., Escudero-Esparza, A., Orimo, A., Leandersson, K., Hagerling, C., Aspberg, A., Storm, P., Okroj, M., Mulder, H., Jirstrom, K., Pietras, K., & Blom, A. M. (2016). Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer. Oncogene, 35(43), 5585–5596.CrossRefPubMed

11.

Englund, E., Canesin, G., Papadakos, K. S., Vishnu, N., Persson, E., Reitsma, B., Anand, A., Jacobsson, L., Helczynski, L., Mulder, H., Bjartell, A., & Blom, A. M. (2017). Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis. Oncotarget, 8(58), 98298–98311.CrossRefPubMedPubMedCentral

12.

Li, Q., Wang, C., Wang, Y., Sun, L., Liu, Z., Wang, L., Song, T., Yao, Y., Liu, Q., & Tu, K. (2018). HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways. Journal of Experimental & Clinical Cancer Research, 37(1), 018–0908.CrossRef

13.

Liu, T. T., Liu, X. S., Zhang, M., Liu, X. N., Zhu, F. X., Zhu, F. M., Ouyang, S. W., Li, S. B., Song, C. L., Sun, H. M., Lu, S., Zhang, Y., Lin, J., Tang, H. M., & Peng, Z. H. (2018). Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway. Journal of Cancer Research and Clinical Oncology, 144(6), 1049–1063.CrossRefPubMed

14.

Fu, Y., Huang, Y., Yang, Z., Chen, Y., Zheng, J., Mao, C., Li, Z., Liu, Z., Yu, B., Li, T., Wang, M., Xu, C., Zhou, Y., Zhao, G., Jia, Y., Guo, W., Jia, X., Zhang, T., Li, L., … Kong, W. (2021). Cartilage oligomeric matrix protein is an endogenous β-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury. Cell Research, 31(7), 773–790. https://doi.org/10.1038/s41422-020-00464-8CrossRefPubMedPubMedCentral

15.

Schulz, J.-N., Plomann, M., Sengle, G., Gullberg, D., Krieg, T., & Eckes, B. (2018). New developments on skin fibrosis - Essential signals emanating from the extracellular matrix for the control of myofibroblasts. Matrix Biology, 68–69, 522–532. https://doi.org/10.1016/j.matbio.2018.01.025CrossRefPubMed

16.

Yu, H., Alruwaili, N., Hu, B., Kelly, M. R., Zhang, B., Sun, D., & Wolin, M. S. (2019). Potential role of cartilage oligomeric matrix protein in the modulation of pulmonary arterial smooth muscle superoxide by hypoxia. American Journal of Physiology. Lung Cellular and Molecular Physiology, 317(5), L569–L577.CrossRefPubMedPubMedCentral

17.

Yu, H., Jia, Q., Feng, X., Chen, H., Wang, L., Ni, X., & Kong, W. (2017). Hypoxia decrease expression of cartilage oligomeric matrix protein to promote phenotype switching of pulmonary arterial smooth muscle cells. International Journal of Biochemistry & Cell Biology, 91(Pt A), 37–44.CrossRef

18.

Wang, H., Yuan, Z., Wang, B., Li, B., Lv, H., He, J., Huang, Y., Cui, Z., Ma, Q., Li, T., Fu, Y., Tan, X., Liu, Y., Wang, S., Wang, C., Kong, W., & Zhu, Y. (2022). COMP (cartilage oligomeric matrix protein), a novel PIEZO1 regulator that controls blood pressure. Hypertension, 79(3), 549–561.CrossRefPubMed

19.

Wang, M., Fu, Y., Gao, C., Jia, Y., Huang, Y., Liu, L., Wang, X., Wang, W., & Kong, W. (2016). Cartilage oligomeric matrix protein prevents vascular aging and vascular smooth muscle cells senescence. Biochemical and Biophysical Research Communications, 478(2), 1006–1013.CrossRefPubMed

20.

Sandstedt, J., Vargmar, K., Bjorkman, K., Ruetschi, U., Bergstrom, G., Hulten, L. M., & Skioldebrand, E. (2021). COMP (cartilage oligomeric matrix protein) neoepitope: A novel biomarker to identify symptomatic carotid stenosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 41(3), 1218–1228.CrossRefPubMedPubMedCentral

21.

Yeh, H. W., Lee, S. S., Chang, C. Y., Lang, Y. D., & Jou, Y. S. (2019). A new switch for TGFbeta in cancer. Cancer Research, 79(15), 3797–3805.CrossRefPubMed

22.

Davis, M. D., Suzaki, I., Kawano, S., Komiya, K., Cai, Q., Oh, Y., & Rubin, B. K. (2019). Tissue factor facilitates wound healing in human airway epithelial cells. Chest, 155(3), 534–539.CrossRefPubMed

23.

Seoane, J., & Gomis, R. R. (2017). TGF-beta family signaling in tumor suppression and cancer progression. Cold Spring Harbor Perspectives in Biology, 9(12), a022277.CrossRefPubMedPubMedCentral

24.

Peng, D., Fu, M., Wang, M., Wei, Y., & Wei, X. (2022). Targeting TGF-β signal transduction for fibrosis and cancer therapy. Molecular Cancer. https://doi.org/10.1186/s12943-022-01569-xCrossRefPubMedPubMedCentral

25.

Ge, C., Zhao, Y., Liang, Y., & He, Y. (2022). Silencing of TLR4 inhibits atrial fibrosis and susceptibility to atrial fibrillation via downregulation of NLRP3-TGF-beta in spontaneously hypertensive rats. Disease Markers, 11, 2466150.

26.

Saljic, A., Grandi, E., & Dobrev, D. (2022). TGF-beta1-induced endothelial–mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation? Journal of Clinical Investigation. https://doi.org/10.1172/JCI161070CrossRefPubMedPubMedCentral

27.

Nattel, S., & Harada, M. (2014). Atrial remodeling and atrial fibrillation: Recent advances and translational perspectives. Journal of the American College of Cardiology, 63(22), 2335–2345.CrossRefPubMed

28.

Woods, C. E., & Olgin, J. (2014). Atrial fibrillation therapy now and in the future: Drugs, biologicals, and ablation. Circulation Research, 114(9), 1532–1546.CrossRefPubMedPubMedCentral

29.

Chen, D., Qin, Y., Dai, M., Li, L., Liu, H., Zhou, Y., Qiu, C., Chen, Y., & Jiang, Y. (2020). BGN and COL11A1 regulatory network analysis in colorectal cancer (CRC) reveals that BGN influences CRC cell biological functions and interacts with miR-6828-5p. Cancer Management and Research, 12, 13051–13069. https://doi.org/10.2147/cmar.s277261CrossRefPubMedPubMedCentral

30.

Beigel, R., Wunderlich, N. C., Ho, S. Y., Arsanjani, R., & Siegel, R. J. (2014). The left atrial appendage: Anatomy, function, and noninvasive evaluation. JACC: Cardiovascular Imaging, 7(12), 1251–1265.PubMed

31.

Dzeshka, M. S., Lip, G. Y., Snezhitskiy, V., & Shantsila, E. (2015). Cardiac fibrosis in patients with atrial fibrillation: Mechanisms and clinical implications. Journal of the American College of Cardiology, 66(8), 943–959.CrossRefPubMed

32.

Ajoolabady, A., Nattel, S., Lip, G. Y. H., & Ren, J. (2022). Inflammasome signaling in atrial fibrillation: JACC state-of-the-art review. Journal of the American College of Cardiology, 79(23), 2349–2366.CrossRefPubMed

33.

Orlov, Y. L., Anashkina, A. A., Klimontov, V. V., & Baranova, A. V. (2021). Medical genetics, genomics and bioinformatics aid in understanding molecular mechanisms of human diseases. International Journal of Molecular Sciences, 22(18), 9962.CrossRefPubMedPubMedCentral

34.

Cui, J., & Zhang, J. (2022). Cartilage oligomeric matrix protein, diseases, and therapeutic opportunities. International Journal of Molecular Sciences, 23(16), 9253. https://doi.org/10.3390/ijms23169253CrossRefPubMedPubMedCentral

35.

Maly, K., Andres Sastre, E., Farrell, E., Meurer, A., & Zaucke, F. (2021). COMP and TSP-4: Functional roles in articular cartilage and relevance in osteoarthritis. International Journal of Molecular Sciences, 22(5), 2242.CrossRefPubMedPubMedCentral

36.

Caron, M. M. J., Janssen, M. P. F., Peeters, L., Haudenschild, D. R., Cremers, A., Surtel, D. A. M., van Rhijn, L. W., Emans, P. J., & Welting, T. J. M. (2020). Aggrecan and COMP improve periosteal chondrogenesis by delaying chondrocyte hypertrophic maturation. Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe.2020.01036CrossRefPubMedPubMedCentral

37.

Idriss, N. K., Gamal, R. M., Gaber, M. A., El-Hakeim, E. H., Hammam, N., Ghandour, A. M., Abdelaziz, M. M., & Goma, S. H. (2020). Joint remodeling outcome of serum levels of Dickkopf-1 (DKK1), cartilage oligomeric matrix protein (COMP), and C-telopeptide of type II collagen (CTXII) in rheumatoid arthritis. Central European Journal of Immunology, 45(1), 73–79.CrossRefPubMedPubMedCentral

38.

Nishida, Y., Hashimoto, Y., Orita, K., Nishino, K., Kinoshita, T., & Nakamura, H. (2022). Serum cartilage oligomeric matrix protein detects early osteoarthritis in patients with anterior cruciate ligament deficiency. Arthroscopy, 38(3), 873–878.CrossRefPubMed

39.

Zachou, K., Gabeta, S., Shums, Z., Gatselis, N. K., Koukoulis, G. K., Norman, G. L., & Dalekos, G. N. (2017). COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis. European Journal of Internal Medicine, 38, 83–88.CrossRefPubMed

40.

Agarwal, P., Schulz, J. N., Blumbach, K., Andreasson, K., Heinegard, D., Paulsson, M., Mauch, C., Eming, S. A., Eckes, B., & Krieg, T. (2013). Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies. Matrix Biology, 32(6), 325–331.CrossRefPubMed

41.

Inui, S., Shono, F., Nakajima, T., Hosokawa, K., & Itami, S. (2011). Identification and characterization of cartilage oligomeric matrix protein as a novel pathogenic factor in keloids. American Journal of Pathology, 179(4), 1951–1960.CrossRefPubMedPubMedCentral

42.

Jansa, V., Klancic, T., Pusic, M., Klein, M., Vrtacnik Bokal, E., Ban Frangez, H., & Rizner, T. L. (2021). Proteomic analysis of peritoneal fluid identified COMP and TGFBI as new candidate biomarkers for endometriosis. Science and Reports, 11(1), 021–00299.

43.

Bartosinska, J., Michalak-Stoma, A., Juszkiewicz-Borowiec, M., Kowal, M., & Chodorowska, G. (2015). The assessment of selected bone and cartilage biomarkers in psoriatic patients from Poland. Mediators of Inflammation, 194535(10), 4.

44.

Denton, N., Pinnick, K. E., & Karpe, F. (2018). Cartilage oligomeric matrix protein is differentially expressed in human subcutaneous adipose tissue and regulates adipogenesis. Molecular Metabolism, 16, 172–179.CrossRefPubMedPubMedCentral

45.

Schulz, J., Plomann, M., Sengle, G., Gullberg, D., Krieg, T., & Eckes, B. (2018). New developments on skin fibrosis—Essential signals emanating from the extracellular matrix for the control of myofibroblasts. Matrix Biology: Journal of the International Society for Matrix Biology. https://doi.org/10.1016/j.matbio.2018.01.025CrossRefPubMed

46.

Vuga, L., Milosevic, J., Pandit, K., Ben-Yehudah, A., Chu, Y., Richards, T., Sciurba, J., Myerburg, M., Zhang, Y., Parwani, A., Gibson, K., & Kaminski, N. (2013). Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis. PLoS ONE, 8(12), e83120. https://doi.org/10.1371/journal.pone.0083120CrossRefPubMedPubMedCentral

Title: COMP Improves Ang-II-Induced Atrial Fibrillation via TGF-β Signaling Pathway
Authors: XiaoBi Cai
Mingliang Li
Ying Zhong
Wenkun Yang
Zhu Liang
Publication date: 16-08-2023
Publisher: Springer US
Keyword: Atrial Fibrillation
Published in: Cardiovascular Toxicology / Issue 9-10/2023
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-023-09799-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

COMP Improves Ang-II-Induced Atrial Fibrillation via TGF-β Signaling Pathway

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9-10/2023

Klotho/FGF23 Axis Regulates Cardiomyocyte Apoptosis and Cytokine Release through ERK/MAPK Pathway

Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways

Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with Breast Cancer

Targeting Retinol-Binding Protein 4 (RBP4) in the Management of Cardiometabolic Diseases